Drug Induced Liver Injury (DILI)
Drugs are an important reason for liver injury. Liver injury occurs because of use of more than 900 drugs, toxins, and herbs and drugs represent 20 – 40 percent of all instances of fulminant liver failure. Around 75 percent of the idiosyncratic drug reactions will leads to transplantation of liver or even death sometimes. Drug Hepatotoxicity is the most common reason for withdrawal of an approved drug. Doctors must be vigilant in recognizing drug-related liver injury as because if it will be detected earlier, then it could decrease the severity of hepatotoxicity if the drug is discontinued. The illustrations of DILI are highly variable, ranging from asymptomatic elevation of liver enzymes to fulminant liver failure. Information on commonly implicated agents and a high index of suspicion are very much essential in diagnosis.
In U.S.A., around 200 cases of acute liver failure occur every year and drugs account for over 50% of them (39% are because of acetaminophen, 13% are idiosyncratic reaction because of other meds). Drugs accounts for 2-5% of cases of patients who all are hospitalized with jaundice and around 10% of all cases of acute hepatitis.
Related Conference of Drug Induced Liver Injury (DILI)
20th World Congress on Gastroenterology -Therapeutics & Hepatology
Drug Induced Liver Injury (DILI) Conference Speakers
Recommended Sessions
- Drug Induced Liver Injury (DILI)
- HCV/HIV Coinfection
- Hepatitis B and Other Viral Hepatitis
- Liver Cancer
- Liver Fibrosis
- Liver Growth and Repair
- Liver Imaging Modalities
- Liver Inflammation and Immunology
- Liver Transplantation and Liver Surgery (Experimental & Clinical)
- Molecular and Cellular Biology
- Other Liver Diseases
- Pediatric Hepatology
- Viral Hepatitis C
Related Journals
Are you interested in
- Advanced GI Endoscopy Techniques - Gastroenterology Conference 2026 (France)
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Alcoholic Liver Disease Studies - Gastroenterology Conference 2026 (France)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Artificial Intelligence & Digital Health in GI - Gastroenterology Conference 2026 (France)
- Autoimmune Liver Disorders - Gastroenterology Conference 2026 (France)
- Bariatric Surgery & Obesity-Related GI Disorders - Gastroenterology Conference 2026 (France)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Cholangiocarcinoma Research - Gastroenterology Conference 2026 (France)
- Clinical Trials & Translational Research - Gastroenterology Conference 2026 (France)
- Digestive Health’s, Therapeutics & Diagnostics - Gastrosummit 2026 (UK)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Endoscopic Ultrasound (EUS) & Advanced Imaging - Gastroenterology Conference 2026 (France)
- Endoscopists - Gastrosummit 2026 (UK)
- Endoscopy - Gastrosummit 2026 (UK)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Gastroenterologists - Gastrosummit 2026 (UK)
- Gastroenterology - Gastrosummit 2026 (UK)
- Gastrointestinal - Gastrosummit 2026 (UK)
- Gastrointestinal Disorders: Clinical Updates - Gastroenterology Conference 2026 (France)
- Gastrointestinal Oncology - Gastroenterology Conference 2026 (France)
- Gastrointestinal Polyposis Syndromes - Gastroenterology Conference 2026 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Geriatric Gastroenterology & Liver Disorders - Gastroenterology Conference 2026 (France)
- GI Bleeding & Hemostasis Innovations - Gastroenterology Conference 2026 (France)
- GI Surgeons - Gastrosummit 2026 (UK)
- Global Health & Public Health Challenges in GI & Liver - Gastroenterology Conference 2026 (France)
- Gut Microbiome & Therapeutics - Gastroenterology Conference 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma & Liver Tumor Management - Gastroenterology Conference 2026 (France)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatologists - Gastrosummit 2026 (UK)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2026 (UK)
- Inflammatory Bowel Disease Research - Gastroenterology Conference 2026 (France)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Disease: Chronic and Acute Management - Gastroenterology Conference 2026 (France)
- Liver Disorders - Gastrosummit 2026 (UK)
- Liver Transplantation Innovations - Gastroenterology Conference 2026 (France)
- Microbiome - Gastrosummit 2026 (UK)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Minimally Invasive Gastrointestinal Surgery - Gastroenterology Conference 2026 (France)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease (NAFLD) & NASH - Gastroenterology Conference 2026 (France)
- Nutrition, Diet, and Lifestyle in GI & Liver Health - Gastroenterology Conference 2026 (France)
- Oncologists - Gastrosummit 2026 (UK)
- Oncologists - Gastrosummit 2026 (UK)
- Palliative Care & Quality of Life in GI & Liver Disorders - Gastroenterology Conference 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adult Liver Metabolic Disorders - Gastroenterology Conference 2026 (France)
- Pediatric Gastroenterology & Hepatology - Gastroenterology Conference 2026 (France)
- Pharmacology & Novel Therapeutics - Gastroenterology Conference 2026 (France)
- Precision Medicine - Gastrosummit 2026 (UK)
- Precision Medicine & Biomarkers in Gastroenterology & Hepatology - Gastroenterology Conference 2026 (France)
- Public Health - Gastrosummit 2026 (UK)
- Rare GI & Liver Disorders - Gastroenterology Conference 2026 (France)
- Regenerative Medicine in Liver & GI Disorders - Gastroenterology Conference 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis Research - Gastroenterology Conference 2026 (France)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)

